Steatotic liver disease, including metabolic dysfunction associated steatohepatitis (MASLD) and metabolic associated alcoholic liver disease (MALD), is a common cause of liver test abnormalities in the United States. Risk factors such as obesity and metabolic syndrome can lead to advanced fibrosis a

2 views • 44 slides

Liver complications in cystic fibrosis (CF) have gained importance due to CFTR modulators impacting liver health. This presentation by Dr. Zachary M. Sellers delves into new definitions for CF liver disease, CFF recommendations for screening, management, and treatment of hepatobiliary issues in CF.

0 views • 17 slides

This presentation explores the effects of sustained stress on the body, particularly in the context of caring for individuals with chronic conditions like cystic fibrosis. It delves into the physiological responses to stress, the unavoidable stressors faced by caregivers, and the detrimental impacts

1 views • 14 slides

Nontuberculous mycobacteria (NTM) infections present a significant challenge in individuals with cystic fibrosis (CF). These infections are caused by over 200 species of atypical mycobacteria found in various environments. The CF-ID Clinic plays a crucial role in managing patients with multi-drug re

2 views • 25 slides

HRCT plays a crucial role in diagnosing and monitoring fibrosing interstitial lung diseases (ILDs). It helps identify abnormalities not visible on X-rays, leading to early, accurate diagnoses and potentially avoiding invasive procedures. HRCT assists in distinguishing specific ILDs based on radiogra

1 views • 25 slides

Cystic Fibrosis (CF) is a genetic disease caused by variants in the CFTR gene. CFTR is a crucial membrane protein responsible for chloride transport in epithelial cells, impacting organ function. The Modulator Era focuses on CFTR modulators approved by the FDA for treating CF and improving outcomes.

0 views • 63 slides

Explore the latest pharmaceutical additions and clinical edits in the MO HealthNet Pharmacy Program for various conditions like Fabry disease, cystic fibrosis, generalized myasthenia gravis, and more. Discover new medications such as Elfabrio, Kalydeco, Rystiggo, and Trikafta along with their indica

1 views • 19 slides

Human genetic disorders encompass a range of conditions, from recessive disorders like cystic fibrosis to dominant disorders such as Huntington's disease. Examples include cystic fibrosis, Huntington's disease, and sickle-cell anemia. Understanding genetic disorders involves research and awareness o

0 views • 10 slides

Myeloproliferative neoplasms (MPNs) include a group of disorders characterized by overproduction of blood cells. The WHO classification outlines eight disorders with varied clinical presentations and potential for transformation. These disorders, such as CML, CNL, and PV, exhibit significant phenoty

2 views • 58 slides

Creating an effective daily respiratory therapy regimen is crucial for adults with Cystic Fibrosis (CF) to maintain healthy lungs and good lung function. This includes inhaled medications such as nebulizer treatments and bronchodilators, airway clearance techniques like the Vest and Pep devices, as

0 views • 32 slides

Superior Vena Cava (SVC) occlusion secondary to postradiation fibrosis is a rare condition that can lead to debilitating symptoms. In this case study, a 47-year-old male with a history of Hodgkin lymphoma treated with chest radiotherapy presented with exertional chest pain and other associated sympt

1 views • 19 slides

Systemic sclerosis (SScl) is an autoimmune disorder affecting connective tissue, leading to fibrosis in the skin, internal organs, and vasculature. It is characterized by Raynaud's phenomenon, digital ischemia, sclerodactyly, and cardiac, lung, gut, and renal involvement. Peak onset is in the fourth

1 views • 28 slides

The intervertebral disc, a crucial component of the spine, can be affected by prolapse, leading to various stages of PIVD. The condition involves the nucleus pulposus bulging out due to tears in the annulus fibrosis. The stages of PIVD include bulging disc, protrusion, extrusion, and sequestrization

0 views • 36 slides

The Nernst Equation is derived to provide insight into membrane potential and its role in various health conditions like cystic fibrosis and epilepsy. This derivation involves combining diffusive flux, electric drift, and mobility terms, leading to a deeper understanding of membrane behavior. The Bo

1 views • 26 slides

Dr. Andrew Thurston, a GP, emphasizes the importance of investigations like PEFR, spirometry, and more in the diagnosis of respiratory conditions such as asthma, COPD, and pulmonary fibrosis. The provided spirometry results for a 56-year-old woman prompt consideration of the most likely diagnosis. S

0 views • 140 slides

Actinobacillosis, also known as Wooden Tongue, is a specific infectious disease affecting cattle and sheep, caused by Actinobacillus lignieresii. It is characterized by fibrosis of the tongue and soft tissues, leading to mobility issues. The disease is primarily transmitted through wounds and abrasi

0 views • 8 slides

Genetics is a fascinating field that influences our health and traits. Part 2 of our guide explores topics such as cystic fibrosis, family pedigrees, and sex-linked genetic disorders. Learn about the inheritance patterns, carrier statuses, and implications of these genetic conditions through detaile

0 views • 15 slides

Pathological pigmentation involves the abnormal deposition of pigments in the body. It can be classified as exogenous or endogenous, with various sources and types of pigments. Melanin, one of the endogenous pigments, plays a crucial role in determining tissue color and can have protective functions

5 views • 23 slides

Degenerative spine disease is a prevalent condition affecting millions, leading to substantial healthcare costs. The anatomy and physiology of spine degeneration involve the three-joint complex theory. Pathologically, disc degeneration impacts the nucleus pulposus and annulus fibrosis, contributing

0 views • 37 slides

Core trainers in CPG management of Chronic Hepatitis C in adults must focus on pre-treatment assessment to identify co-morbidities, assess liver status, determine fibrosis severity, and conduct necessary blood investigations. Utilizing non-invasive methods for liver fibrosis assessment is crucial fo

0 views • 13 slides

Explore the latest advancements in the treatment of Hepatitis C virus (HCV) in HIV-infected individuals through a detailed presentation by Dr. Kara W. Chew. Learn about the initial evaluation for HCV, treatment options for different genotypes, management of advanced fibrosis, recommended approaches

0 views • 9 slides

Studying infants with cystic fibrosis exposed to secondhand smoke revealed that those in smoke-free homes experienced better growth and lower risk of bacterial infections compared to those with smoking parents. Creating a quit plan for smokers is essential to improve health outcomes and prevent rela

2 views • 25 slides

A phase 2 study on NGM282 in NASH patients showed a significant decrease in liver fat content, meeting the primary endpoint. Exploratory findings also indicated potential improvements in liver histology. The treatment involved NGM282 at 3 mg QD, with additional rosuvastatin if needed. Promising resu

0 views • 11 slides

This Phase 2 clinical trial compares the efficacy of NGM282 (3 mg vs 6 mg) versus placebo in patients with NASH. The primary endpoint is a 5% reduction in liver fat content at 12 weeks. Randomisation was stratified by diabetes status, and stable Type 2 diabetes and lipid-lowering treatments were mai

0 views • 6 slides

Tissue repair involves complex mechanisms like regeneration by parenchymal cells or fibrosis leading to scar formation. Inflammatory cells play a crucial role in tissue repair, along with processes like ECM synthesis and cell migration. Different types of cells in the body have varying regenerative

0 views • 20 slides

Tissue regeneration and repair processes involve either regeneration of cells or connective tissue repair, depending on the type of cells injured. In cases where regeneration is not possible, healing occurs through the formation of scar tissue. The healing process aims to restore the structural cont

0 views • 40 slides

Tissue repair involves two primary mechanisms: regeneration, where some tissues can replace damaged cells, and fibrosis, where scar tissue forms if regeneration is not possible. Cell proliferation, growth factors, and cell population control play key roles in the restoration of tissue architecture a

0 views • 15 slides

The body's response to injury involves two main processes of wound healing - regeneration and repair. Regeneration involves proliferation of parenchymatous cells, while repair results in fibrosis and scarring by proliferation of connective tissue. Different types of cells play varying roles in the h

0 views • 12 slides

Silica exposure poses serious health risks as respirable crystalline silica particles can penetrate the body's natural defenses, leading to conditions like silicosis, tuberculosis, lung cancer, and chronic bronchitis. The silica particles that bypass initial defenses can cause inflammation and fibro

0 views • 17 slides

This comprehensive review discusses the pharmacotherapy options for Non-Alcoholic Fatty Liver Disease (NAFLD), covering topics such as sub-classification of NAFLD, proposed risk stratification, non-invasive measures for assessing liver fibrosis, and the NAFLD Activity Score (NAS). Anita Eftekharzade

0 views • 44 slides

Breathing exercises are essential interventions for managing pulmonary disorders like COPD, cystic fibrosis, and post-operative complications. They help improve ventilation, cough effectiveness, muscle strength, and reduce stress. Different types of exercises like diaphragmatic breathing and pursed

0 views • 13 slides

Optimizing growth and weight gain is crucial for children with cystic fibrosis (CF) to enhance health outcomes and survival. Behavioral barriers often hinder patients from achieving nutrition goals, but interventions combining nutrition and behavioral strategies have shown effectiveness. This approa

0 views • 27 slides

Cystic Fibrosis (CF) is a genetic condition affecting around 11,000 people in the UK. It disrupts salt and water movement in cells, leading to thicker, stickier mucus in the body. This condition can affect the lungs, digestive system, and pancreas, with symptoms such as chronic cough, digestive issu

0 views • 23 slides

The Human Genome Project, completed in 2003, aimed to identify all human genes and DNA sequences. Genetic disorders, like autosomal disorders and Huntington's disease, can result from mutations at different levels, affecting single genes, chromosomes, or multiple genes. Albinism and cystic fibrosis

0 views • 37 slides

Steatosis has emerged as a significant diagnosis with NAFLD becoming a common cause for hepatologic evaluation. Liver stiffness measurement (LSM) using transient elastography is vital for assessing fibrosis severity in NAFLD patients. However, the accuracy of LSM can be influenced by obesity and sev

0 views • 35 slides

Pterygium, a common ocular surface lesion, has historically been considered degenerative due to factors like UV radiation exposure. However, recent research suggests an inflammatory component with cellular proliferative fibrosis and angiogenesis. This study presented at TOSCON 2024 delves into the h

0 views • 6 slides

Monash University researchers have developed a groundbreaking non-invasive technology to diagnose and manage respiratory lung diseases, such as cystic fibrosis and lung cancer. The technology, utilizing four-dimensional X-ray velocity imaging, provides high-definition real-time images of airflow in

0 views • 4 slides

Smad7 knockout leads to increased Collagen 1 gene levels in kidney cells, potentially contributing to renal fibrosis. Lack of Smad7 protein may result in overproduction of Collagen 1. This protein is found in the extracellular matrix and plays a crucial role in kidney fibrosis pathways, such as TGF-

0 views • 12 slides

Explore the nutrition implications and management strategies for CF-related liver disease, gastrointestinal complications, and CF-related diabetes in patients. Learn about the proposed mechanisms, prevalence rates, and consequences of hepatic complications in cystic fibrosis. Gain insights into neon

0 views • 23 slides

The Stanford Adult CF PFAC works to enhance patient and family experiences at Stanford Health Care's Cystic Fibrosis Center. Initiatives include establishing a memorial space, exploring home FEV1 monitoring, capturing patient encounters for teaching, and collaborating with the CFF for clinic develop

0 views • 11 slides